Insider TradingJul 28, 2026, 07:01 AM
OKYO Pharma CSO Raj Patil Increases Shareholdings
AI Summary
OKYO Pharma Ltd announced that its Chief Scientific Officer, Raj Patil, PhD, increased his stake in the company. He purchased 3,363 ordinary shares on NASDAQ at a price of $1.49 per share, bringing his total ownership to 20,030 ordinary shares.
Key Highlights
- Chief Scientific Officer Raj Patil purchased 3,363 ordinary shares.
- Shares were acquired on NASDAQ at $1.49 per share.
- Total holdings for Raj Patil now stand at 20,030 ordinary shares.
Price Impact
More from OKYO